These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 14522251)
1. Prolyl isomerase Pin1 as a molecular target for cancer diagnostics and therapeutics. Lu KP Cancer Cell; 2003 Sep; 4(3):175-80. PubMed ID: 14522251 [No Abstract] [Full Text] [Related]
2. Phosphorylation-specific prolyl isomerase Pin1 as a new diagnostic and therapeutic target for cancer. Finn G; Lu KP Curr Cancer Drug Targets; 2008 May; 8(3):223-9. PubMed ID: 18473735 [TBL] [Abstract][Full Text] [Related]
3. The prolyl isomerase Pin1 interacts with a ribosomal protein S6 kinase to enhance insulin-induced AP-1 activity and cellular transformation. Lee NY; Choi HK; Shim JH; Kang KW; Dong Z; Choi HS Carcinogenesis; 2009 Apr; 30(4):671-81. PubMed ID: 19168580 [TBL] [Abstract][Full Text] [Related]
4. Phosphorylation-specific prolyl isomerization: is there an underlying theme? Wulf G; Finn G; Suizu F; Lu KP Nat Cell Biol; 2005 May; 7(5):435-41. PubMed ID: 15867923 [TBL] [Abstract][Full Text] [Related]
5. Prolyl isomerase Pin1: a catalyst for oncogenesis and a potential therapeutic target in cancer. Ryo A; Liou YC; Lu KP; Wulf G J Cell Sci; 2003 Mar; 116(Pt 5):773-83. PubMed ID: 12571275 [TBL] [Abstract][Full Text] [Related]
6. The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease. Lu KP; Zhou XZ Nat Rev Mol Cell Biol; 2007 Nov; 8(11):904-16. PubMed ID: 17878917 [TBL] [Abstract][Full Text] [Related]
7. The role of Pin1 in the development and treatment of cancer. Min SH; Zhou XZ; Lu KP Arch Pharm Res; 2016 Dec; 39(12):1609-1620. PubMed ID: 27572155 [TBL] [Abstract][Full Text] [Related]
8. The Roles of the Unique Prolyl Isomerase Pin1 in Cancer-Related Viral and Bacterial Infections. Wang J; Liao XH; Zheng M; Yang D; Zhou XZ; Liu H; Lu KP Curr Mol Med; 2016; 16(9):793-802. PubMed ID: 27889995 [TBL] [Abstract][Full Text] [Related]
9. Prolyl cis/trans isomerase signalling pathways in cancer. Theuerkorn M; Fischer G; Schiene-Fischer C Curr Opin Pharmacol; 2011 Aug; 11(4):281-7. PubMed ID: 21497135 [TBL] [Abstract][Full Text] [Related]
10. Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1. Wulf GM; Ryo A; Wulf GG; Lee SW; Niu T; Petkova V; Lu KP EMBO J; 2001 Jul; 20(13):3459-72. PubMed ID: 11432833 [TBL] [Abstract][Full Text] [Related]
11. Peptidyl-prolyl cis-trans isomerase Pin1 in ageing, cancer and Alzheimer disease. Lee TH; Pastorino L; Lu KP Expert Rev Mol Med; 2011 Jun; 13():e21. PubMed ID: 21682951 [TBL] [Abstract][Full Text] [Related]
12. [Recent advances in the study of pin1 and its inhibitors]. Zhang CJ; Zhang ZH; Xu BL; Wang YL Yao Xue Xue Bao; 2008 Jan; 43(1):9-17. PubMed ID: 18357725 [TBL] [Abstract][Full Text] [Related]
13. Pin1: a molecular orchestrator in the heart. Hariharan N; Sussman MA Trends Cardiovasc Med; 2014 Aug; 24(6):256-62. PubMed ID: 25070718 [TBL] [Abstract][Full Text] [Related]
14. Pin1 as an anticancer drug target. Xu GG; Etzkorn FA Drug News Perspect; 2009 Sep; 22(7):399-407. PubMed ID: 19890497 [TBL] [Abstract][Full Text] [Related]
15. The peptidyl-prolyl isomerase Pin1. Joseph JD; Yeh ES; Swenson KI; Means AR; Winkler Prog Cell Cycle Res; 2003; 5():477-87. PubMed ID: 14593743 [TBL] [Abstract][Full Text] [Related]
16. [Pin1: a multi-talented peptidyl prolyl cis-trans isomerase and a promising therapeutic target for human cancers]. Marsolier J; Weitzman JB Med Sci (Paris); 2014; 30(8-9):772-8. PubMed ID: 25174754 [TBL] [Abstract][Full Text] [Related]